New Study Showed Consistent Glycemic Outcomes Across Sensors Integrated with MiniMed 780G System

Randomized crossover trial reinforces SmartGuard™ algorithm as key driver of automated insulin delivery performance NORTHRIDGE, Calif., May 21, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced results from a new randomized crossover...